MINNEAPOLIS, March 22, 2016 -- Charles H. Johnson & Associates announces that it has begun an investigation into the merger/inversion of LivaNova plc (formerly Cyberonics, Inc, a Delaware corporation, “Cyberonics”) and Sorin, S.p.A (“Sorin”), pursuant to which Cyberonics moved its corporate domicile from Delaware to the United Kingdom. On September 24, 2015, Cyberonics announced that its shareholders had approved the merger.
The acquisition was structured as a “tax inversion” to substantially lower Cyberonics’ tax rate on its foreign earnings by replacing the U.S. tax rates to which its foreign earnings were subject with the much lower United Kingdom tax rate.
Because it was structured as an inversion, the merger was treated as taxable to Cyberonics shareholders as it was considered a sale by Cyberonics shareholders of their shares, rather than a tax-free exchange as is typically the case in such transactions. Many Cyberonics shareholders who had held their stock for more than a year were forced to pay federal taxes at rates of 15% to 30% on their gains, in addition to state taxes.
The investigation is looking into whether the Cyberonics Board of Directors adequately represented the interests of Cyberonics’ shareholders in connection with the Sorin acquisition and, if not, whether such failure constituted a breach of fiduciary duty by the Cyberonics Board of Directors and whether Cyberonics or others aided and abetted such breach or violated other laws.
If you held Cyberonics stock and were subject to capital gains or other taxes due to the Sorin acquisition, or have any questions concerning this notice or your rights with respect to this matter, please contact:
Jonathan R. Mencel, Esq. ([email protected])
Law Offices of Charles H. Johnson, P.A.
2599 Mississippi Street
New Brighton, MN 55112
(651) 633-5685


Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 



